Clinical Trial Update: A Five-Treatment-Period Study to Evaluate the Single-Dose Pharmacokinetics and Pharmacodynamics of Avatrombopag in Healthy Japanese and White Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing single-dose pharmacokinetics and pharmacodynamics of avatrombopag in healthy Japanese and White subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Eisai Inc. | Conditions: Thrombocytopenia | Phase 1 | Status: COMPLETED